-
According to a press statement, the OU-Tulsa branch will start seeing patients and conduct clinical trials as soon as this summer.
-
Drug company reps commonly visit doctors to talk about new medications. A team of economists wanted to know if that helps patients live longer. They found that for cancer patients, the answer is no.
-
Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.
-
It can be easy to get your hopes up about exciting new research or alternative approaches to cancer treatment. Here's an insider's guide for figuring out which ones are worth your time.
-
Medicare suddenly stopped paying for the pricey drug that prolongs his life. As he waits for an appeal, this retired physician wonders if he should give up treatment to spare his family the cost.
-
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who went through the treatment share their stories.
-
KOSU is putting together a series of FAQ guides on reproductive healthcare questions. With conversations happening all around us on what is or isn’t legal following the overturn of Roe v. Wade, we’re wanting to cut straight to what we do know. This guide is part one of two that focuses on reproductive health emergencies in Oklahoma.
-
Oklahoma medical researchers announced Wednesday they have a cancer drug headed to human trials.
-
Keyla "Nunny" Reece was diagnosed with stage 4 metastatic breast cancer at age 39. Photographer Angelica Edwards documented the hardships and moments of joy in Reece's experience with cancer.
-
Patients with advanced cancer and heart disease are among those who have had to wait for surgeries and other procedures as critically ill, unvaccinated COVID patients strain the medical system.